LaFleur & Godfrey LLC Boosts Stock Holdings in Kenvue Inc. $KVUE

Key Points

• LaFleur & Godfrey LLC increased its stake in Kenvue Inc. by 23.7% in the second quarter, owning a total of 165,450 shares worth approximately $3.46 million.
• Kenvue reported earnings of $0.29 EPS for the latest quarter, slightly beating analyst estimates, while its revenue decreased 4.0% year-over-year.
• The company announced a new quarterly dividend of $0.2075 per share, reflecting a dividend yield of 4.5% despite a payout ratio of 112.16%.

LaFleur & Godfrey LLC boosted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 23.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 165,450 shares of the company's stock after buying an additional 31,736 shares during the period. LaFleur & Godfrey LLC's holdings in Kenvue were worth $3,463,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of KVUE. Evergreen Wealth Solutions LLC boosted its position in shares of Kenvue by 2.6% in the first quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock worth $402,000 after buying an additional 432 shares during the period. Fulton Bank N.A. grew its stake in Kenvue by 0.6% in the first quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock valued at $1,892,000 after purchasing an additional 465 shares in the last quarter. Scott & Selber Inc. boosted its position in shares of Kenvue by 0.4% in the first quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after acquiring an additional 475 shares during the period. Wealth Alliance LLC grew its holdings in shares of Kenvue by 1.6% during the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock valued at $762,000 after purchasing an additional 486 shares during the last quarter. Finally, Everett Harris & Co. CA boosted its holdings in Kenvue by 1.4% in the first quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock worth $887,000 after acquiring an additional 500 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Royal Bank Of Canada cut their price target on shares of Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a research report on Friday, August 8th. Bank of America cut their target price on shares of Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Tuesday, July 15th. UBS Group reduced their price objective on shares of Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Canaccord Genuity Group lowered their target price on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a report on Friday, August 8th. Finally, Zacks Research raised shares of Kenvue to a "strong sell" rating in a report on Monday, August 11th. Five investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $24.04.

Kenvue Stock Performance

Kenvue stock traded down $1.38 during trading on Monday, reaching $16.96. The company had a trading volume of 74,831,635 shares, compared to its average volume of 27,946,758. Kenvue Inc. has a 52 week low of $16.89 and a 52 week high of $25.17. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $32.55 billion, a price-to-earnings ratio of 22.92, a price-to-earnings-growth ratio of 2.63 and a beta of 0.83. The firm's 50-day simple moving average is $20.77 and its 200 day simple moving average is $22.00.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The business had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter last year, the business posted $0.32 earnings per share. The business's quarterly revenue was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.9%. The ex-dividend date was Wednesday, August 13th. This is an increase from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio is 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.